Blau Farmacêutica S.A. (BVMF: BLAU3)

Blau Farmacêutica Balance Sheet

Financials in millions BRL. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	20.42	31.5	14.11	51.86	70.2	6.42
Short-Term Investments	-	375.82	629.53	870.96	144.15	152.65
Cash & Short-Term Investments	376.38	407.31	643.65	922.82	214.35	159.06
Cash Growth	-3.92%	-36.72%	-30.25%	330.52%	34.76%	40.83%
Accounts Receivable	521.8	453.56	420.61	331.79	247.55	140.82
Other Receivables	76.56	64.35	44.58	13.66	9.22	13.71
Receivables	598.37	517.91	465.19	345.45	256.78	154.52
Inventory	523.53	628.65	569.02	416.85	327.49	187.57
Other Current Assets	-	-	-	11.35	1.88	-
Total Current Assets	1,498	1,554	1,678	1,696	800.5	501.16
Property, Plant & Equipment	767.28	738.71	542.48	371.58	244.05	154.65
Long-Term Investments	265.19	265.19	-	0.04	0.03	0.03
Goodwill	151.66	151.66	143.24	143.24	144.64	7.07
Other Intangible Assets	47.35	24.83	16.57	5.75	3.48	3
Long-Term Deferred Tax Assets	87.98	81.53	-	-	15.87	9.48
Long-Term Deferred Charges	214.55	177.58	74.25	49.82	21.64	11.32
Other Long-Term Assets	65.81	60.17	44.65	61.14	42.43	51.75
Total Assets	3,098	3,054	2,499	2,328	1,273	738.44
Accounts Payable	152.48	179.92	163.64	116.43	133	85.24
Accrued Expenses	98.68	55.62	56.78	55.2	42.16	18.27
Short-Term Debt	5.16	2.3	-	41.73	15.81	-
Current Portion of Long-Term Debt	64.32	67.92	79.87	49.82	47.01	74.83
Current Portion of Leases	6.07	4.8	3.67	2.11	1.44	-
Current Income Taxes Payable	2.21	-	19.44	19.99	36.23	21.01
Other Current Liabilities	47.4	25.38	47.71	57.72	88.19	63.23
Total Current Liabilities	376.32	335.93	371.11	343.01	363.83	262.57
Long-Term Debt	450	500	200	272.5	626.33	203.89
Long-Term Leases	34.84	33.52	28.17	8.35	0.38	0.21
Long-Term Deferred Tax Liabilities	144.09	125.64	35.02	18.25	-	-
Other Long-Term Liabilities	58.89	63.2	46.81	51.05	60.74	6.02
Total Liabilities	1,064	1,058	681.11	693.16	1,051	472.69
Common Stock	1,317	1,317	1,317	1,317	100.64	100.64
Retained Earnings	785.94	744.37	562.8	325.13	84.64	163.34
Treasury Stock	-42.89	-42.89	-39.9	-	-	-
Comprensive Income & Other	-16.94	-16.62	-17.36	-5.45	36.07	1.78
Total Common Equity	2,043	2,001	1,822	1,636	221.34	265.76
Minority Interest	-8.77	-6.22	-4.22	-1.4	-	-
Shareholders' Equity	2,034	1,995	1,818	1,635	221.34	265.76
Total Liabilities & Equity	3,098	3,054	2,499	2,328	1,273	738.44
Total Debt	560.39	608.54	311.71	374.52	690.96	278.92
Net Cash (Debt)	-184.01	-201.22	331.93	548.3	-476.61	-119.86
Net Cash Growth	-	-	-39.46%	-	-	-
Net Cash Per Share	-1.04	-1.13	1.87	3.06	-3.02	-0.79
Filing Date Shares Outstanding	177.68	177.68	177.83	179.39	148	148
Total Common Shares Outstanding	177.68	177.68	177.83	179.39	148	148
Working Capital	1,122	1,218	1,307	1,353	436.67	238.59
Book Value Per Share	11.50	11.26	10.25	9.12	1.50	1.80
Tangible Book Value	1,844	1,825	1,662	1,487	73.22	255.69
Tangible Book Value Per Share	10.38	10.27	9.35	8.29	0.49	1.73
Machinery	324.17	302.14	170.92	135.22	121.52	86.89
Construction In Progress	263.42	257.03	210.19	194.06	84.28	69.08

Source: S&P Capital IQ. Standard template. Financial Sources.